Articles & Issues
- Language
- English
- Conflict of Interest
- In relation to this article, we declare that there is no conflict of interest.
- Publication history
-
Received March 6, 2010
Accepted April 28, 2010
- This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © KIChE. All rights reserved.
All issues
Formation of abnormally large-sized tubular amyloid β aggregates on a nanostructured gold surface
School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul 151-742, Korea 1Department of Chemical Engineering, Kwangwoon University, Wolgye-dong, Nowon-gu, Seoul 139-701, Korea 2National Institute of Environmental Research, Incheon 404-708, Korea
Korean Journal of Chemical Engineering, January 2011, 28(1), 184-188(5), 10.1007/s11814-010-0314-4
Download PDF
Abstract
The effect of the properties of a nanostructured gold surface (nano-Au surface) on the aggregation of Amyloid β(1-40) (Aβ40) was investigated. A nano-Au surface, in the form of immobilized nanoparticles, was prepared by using a thermal evaporator, resulting in the formation of nanosized clusters with sizes less than 10 nm. When Aβ40 was incubated with the nano-Au surface, abnormally large-sized tubular aggregates were formed on the surface and typical fibril formation was suppressed in the solution. This abnormally large tubular structure represents a novel type of Aβ40 aggregate. In the absence of the nano-Au surface, the diameters of the Aβ40 fibrils were less than 10 nm. However, the height of the tubular aggregates formed on a nano-Au surface was 80-100 nm. Such large-sized aggregates of Aβ40 have not been reported in previous studies dealing with interactions of suspended nanoparticles with proteins. This can be attributed to differences in the aggregation mechanism between immobilized and suspended nanoparticles. The formation of Aβ40 aggregates by nano-Au surface will provide the possible mechanism for abnormal fibril formation.
References
Lynch I, Dawson KA, Nano Today., 3, 40 (2008)
Park J, Kwak BK, Bae E, Lee J, Choi K, Yi J, Kim Y, Korean J. Chem. Eng., 26(6), 1630 (2009)
Colvin VL, Kulinowski KM, Natl. Acad. Sci. USA., 104, 8679 (2007)
Linse S, Cabaleiro-Lago, Xue WF, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA, Proc. Natl. Acad. Sci. USA., 104, 8691 (2007)
Zhang D, Neumann O, Wang H, Yuwono VM, Barhoumi A, Perham M, Hartgerink JD, Wittung-Stafshede P, Halas NJ, Nano Lett., 9, 666 (2009)
Wu WH, Sun X, Yu YP, Hu J, Zhao L, Liu Q, Zhao YF, Li YM, Biochem. Biophys. Res. Commun., 373(2), 315 (2008)
Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I, Lindman S, Minogue AM, Thulin E, Walsh DM, Dawson KA, Linse S, J. Am. Chem. Soc., 130(46), 15437 (2008)
Ikeda K, Okada T, Sawada S, Akiyoshi K, Matsuzaki K, Febs Lett., 580, 6587 (2006)
Zhu M, Souillac PO, Ionescu-Zanetti C, Carter SA, Fink AL, J. Biol. Chem., 277, 50914 (2002)
Stine WBJ, Dahlgren KN, Krafft GA, LaDu MJ, J. Biol.Chem., 278, 11612 (2003)
Ha C, Park CB, Langmuir, 22(16), 6977 (2006)
Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y, J. Biol.Chem., 278, 16462 (2003)
Sigurdsson EM, Amyloid proteins: Methods and protocols., Humana Press, New Jersey (2005)
Stathopulos PB, Scholz GA, Hwang YM, Rumfeldt JO, Lepock JR, Meiering EM, Protein Sci., 13, 3017 (2003)
Kowalewski T, Moltzman DM, Proc. Natl. Acad. Sci. USA., 96, 3688 (1996)
Park J, Kwak BK, Bae E, Lee J, Choi K, Yi J, Kim Y, Korean J. Chem. Eng., 26(6), 1630 (2009)
Colvin VL, Kulinowski KM, Natl. Acad. Sci. USA., 104, 8679 (2007)
Linse S, Cabaleiro-Lago, Xue WF, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA, Proc. Natl. Acad. Sci. USA., 104, 8691 (2007)
Zhang D, Neumann O, Wang H, Yuwono VM, Barhoumi A, Perham M, Hartgerink JD, Wittung-Stafshede P, Halas NJ, Nano Lett., 9, 666 (2009)
Wu WH, Sun X, Yu YP, Hu J, Zhao L, Liu Q, Zhao YF, Li YM, Biochem. Biophys. Res. Commun., 373(2), 315 (2008)
Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I, Lindman S, Minogue AM, Thulin E, Walsh DM, Dawson KA, Linse S, J. Am. Chem. Soc., 130(46), 15437 (2008)
Ikeda K, Okada T, Sawada S, Akiyoshi K, Matsuzaki K, Febs Lett., 580, 6587 (2006)
Zhu M, Souillac PO, Ionescu-Zanetti C, Carter SA, Fink AL, J. Biol. Chem., 277, 50914 (2002)
Stine WBJ, Dahlgren KN, Krafft GA, LaDu MJ, J. Biol.Chem., 278, 11612 (2003)
Ha C, Park CB, Langmuir, 22(16), 6977 (2006)
Ban T, Hamada D, Hasegawa K, Naiki H, Goto Y, J. Biol.Chem., 278, 16462 (2003)
Sigurdsson EM, Amyloid proteins: Methods and protocols., Humana Press, New Jersey (2005)
Stathopulos PB, Scholz GA, Hwang YM, Rumfeldt JO, Lepock JR, Meiering EM, Protein Sci., 13, 3017 (2003)
Kowalewski T, Moltzman DM, Proc. Natl. Acad. Sci. USA., 96, 3688 (1996)